Fields marked with an asterisk (*) are required!
IFU Immunoscore® Colon CE-IVD DE
IFU Immunoscore® Colon CE-IVD EN
IFU Immunoscore® Colon CE-IVD ES
IFU Immunoscore® Colon CE-IVD FR
IFU Immunoscore® Colon CE-IVD IT
Sample Preparation and Shipping Instructions
Request form | DP Service from Stained Slides
Request form | DP Service from Scanned Images
User Guide DPI Service
General Terms and Conditions
Safety Data Sheet
EC Declaration of Conformity
Immunoscore® Colon analytical performance
Prognostic utility of immune markers and validation of Immunoscore® in stage III colon carcinoma patients treated with adjuvant FOLFOX in a phase III trial [NCCTG N0147 (Alliance)]
Journal for ImmunoTherapy of Cancer | Hermitte F.
Presentation of Immunoscore® Colon by Dr J Galon
Presentation of Immunoscore® Colon analytical performance by Fabienne Hermitte, PhD VP, R&D - Regulatory & Medical Affairs
• Objective: Evaluate Immunoscore® as a key risk-factor to optimally adapt chemotherapy prescription in stage III CC...
• HalioDx focuses on exploring and validating the performance of its proprietary diagnostic solutions in multiple cancer...